Nuclear factor-κB1:: Regulation and function

被引:176
|
作者
Pereira, Silvia Gaspar [1 ]
Oakley, Fiona [1 ]
机构
[1] Univ Newcastle, Inst Cellular Med, Liver Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
来源
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | 2008年 / 40卷 / 08期
基金
英国医学研究理事会; 英国惠康基金;
关键词
p50; p105; signaling; function;
D O I
10.1016/j.biocel.2007.05.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor NF-kappa B is a critical regulator of many cellular processes including cell survival and inflammation. NF-kappa B functions as a hetero- or homo-dimer which can be formed from five NF-kappa B subunits, NF-kappa B1 (p50 and its precursor p105), NF-kappa B2 (p52 and its precursor p100), RelA (p65), RelB and c-Rel. The most studied dimer is p50:p65, which is activated by the classical pathway and usually promotes gene expression. Activation of p50:p65 is linked with cell survival and promoting inflammation. This review provides a detailed overview of the structure, synthesis and function of the lesser characterised NF-kappa B subunit; NF-kappa B1 (p 105 and p50). The diverse interactions of NF-kappa B1 with co-activators, co-repressors and other signaling networks that influence NF-kappa B1 gene expression are discussed. Finally the anti-inflammatory actions of NF-kappa B1 signaling will be assessed and the crucial need to design novel therapeutic drugs which exploit and amplify the anti-inflammatory actions of p50 will be explored. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1425 / 1430
页数:6
相关论文
共 50 条
  • [41] Regulation of nuclear factor-κB in intestinal epithelial cells in a cell model of inflammation
    Homaidan, FR
    Chakroun, I
    El-Sabban, ME
    MEDIATORS OF INFLAMMATION, 2003, 12 (05) : 277 - 283
  • [42] Regulation of phospholipase isozymes by nuclear factor-κB in human gestational tissues in vitro
    Lappas, M
    Permezel, M
    Georgiou, HM
    Rice, GE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05): : 2365 - 2372
  • [43] Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit
    Vermeulen, L
    De Wilde, G
    Notebaert, S
    Vanden Berghe, W
    Haegeman, G
    BIOCHEMICAL PHARMACOLOGY, 2002, 64 (5-6) : 963 - 970
  • [44] Nuclear factor-κB in rheumatoid arthritis
    Li, Jie
    Tang, Rong-Shuang
    Shi, Zhou
    Li, Jin-Qi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (12) : 1627 - 1635
  • [45] Role of nuclear factor-κ B in melanoma
    Katayoun I. Amiri
    Ann Richmond
    Cancer and Metastasis Reviews, 2005, 24 : 301 - 313
  • [46] Regulation of IκB kinase ε expression by the androgen receptor and the nuclear factor-κB transcription factor in prostate cancer
    Peant, Benjamin
    Diallo, Jean-Simon
    Lessard, Laurent
    Delvoye, Nathalie
    Le Page, Cecile
    Saad, Fred
    Mes-Masson, Anne-Marie
    MOLECULAR CANCER RESEARCH, 2007, 5 (01) : 87 - 94
  • [47] Nuclear factor-κB mediates up-regulation of cathepsin B by doxorubicin in tumor cells
    Bien, S
    Ritter, CA
    Gratz, M
    Sperker, B
    Sonnemann, J
    Beck, JF
    Kroemer, HK
    MOLECULAR PHARMACOLOGY, 2004, 65 (05) : 1092 - 1102
  • [48] FK506 inhibits tumour necrosis factor-α secretion in human keratinocytes via regulation of nuclear factor-κB
    Lan, CCE
    Yu, HS
    Wu, CS
    Kuo, HY
    Chai, CY
    Chen, GS
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (04) : 725 - 732
  • [49] Expression of nuclear factor-κB and IκBα proteins in prostatic adenocarcinomas:: Correlation of nuclear factor-κB immunoreactivity with disease recurrence
    Ross, JS
    Kallakury, BVS
    Sheehan, CE
    Fisher, HAG
    Kaufman, RP
    Kaur, P
    Gray, K
    Stringer, B
    CLINICAL CANCER RESEARCH, 2004, 10 (07) : 2466 - 2472
  • [50] Nuclear factor-κB:: a transcription factor for all seasons
    Aggarwal, Bharat B.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (02) : 109 - 110